drugset / Trial / NCT06973005
A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the effect of multiple doses of AZD2389 on the pharmacokinetics (PK) of midazolam, caffeine, and bupropion in healthy participants.
Timeline
- Start
- 2025-05-08
- Primary completion
- 2025-07-18
- Completion
- 2025-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2389 | Small molecule | — | Oral |
| Subject | Bupropion | Small molecule | — | Oral |
| Subject | Caffeine | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |